Clinical Trial Update: A Post Market Cohort With the Spinal Modulation Neurostimulator System in Peripheral Neuropathy

View source ↗

Summary

Post-market cohort study of the Spinal Modulation Neurostimulator System in peripheral neuropathy has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Neuropathy

Drugs mentioned

• Spinal Modulation Neurostimulator System

Snippet

Sponsor: Abbott Medical Devices | Conditions: Peripheral Neuropathy | Status: TERMINATED | Results posted: 2018-06-26